Shares shrug off U.S. tech sell-off, vaccine trial halt – Reuters
LONDON (Reuters) – European shares on Wednesday shrugged off heavy losses for U.S. tech stocks and a major drugmaker delaying testing of a coronavirus vaccine, as investors kept faith in an economic recovery from the coronavirus pandemic.
The broad Euro STOXX 600 gained 0.7% in early trading, steadying after hefty declines a day earlier on a rout of tech shares, a key drivers of the stunning recovery for global stocks from coronavirus-induced lows.
London shares .FTSE gained 1%, helped by a …
